共 50 条
Should epitope-based HLA compatibility be used in the kidney allocation system?
被引:21
|作者:
Duquesnoy, Rene J.
[1
]
机构:
[1] Univ Pittsburgh, Med Ctr, Pathol, Pittsburgh, PA 15260 USA
关键词:
HLA;
Antibody;
Epitope;
Eplet;
HLAMatchmaker;
Mismatch acceptability;
Transplantation;
ANTIBODY-DEFINED EPITOPES;
DONOR-SPECIFIC ANTIBODIES;
SENSITIZED PATIENTS;
TRANSPLANTATION;
IMMUNOGENICITY;
PREGNANCY;
ANTIGENICITY;
MISMATCHES;
HLAMATCHMAKER;
PATIENT;
D O I:
10.1016/j.humimm.2016.10.008
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
The new kidney allocation system (KAS) still applies donor-recipient HLA compatibility mostly at the antigen level and although some four-digit alleles have been included. This system is used to record unacceptable mismatches for sensitized transplant candidates with serum HLA antibodies. Since the reactivities of such antibodies are specifically associated with epitopes rather than HLA antigens, a more scientifically accurate assessment of mismatch acceptability could be based on epitopes. HLA class I and class II epitope specificity analyses can now be readily performed with serum antibody assays with single allele panels. This report describes an epitope-based HLA compatibility system for KAS and involves recipient and donor HLA typing at the four-digit allele level. It focuses on sensitized patients who have serum antibodies specific for HLA epitopes that can be entered as unacceptable mismatches in the transplant candidate database. Newly developed software programs could readily identify compatible HLA types. (C) 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文